AZD2014
Showing 1 - 25 of 144
Advanced Solid Malignancies Trial in Chuo-ku, Kashiwa (AZD2014)
Active, not recruiting
- Advanced Solid Malignancies
- AZD2014
-
Chuo-ku, Japan
- +1 more
Feb 2, 2023
Meningioma Trial in Chicago, Boston (AZD2014)
Active, not recruiting
- Meningioma
- AZD2014
-
Chicago, Illinois
- +2 more
Oct 15, 2022
Metastatic Malignant Solid Tumor, Recurrent Lung Small Cell Carcinoma, Recurrent Malignant Solid Tumor Trial in United States
Terminated
- Metastatic Malignant Solid Neoplasm
- +8 more
- Navitoclax
- Vistusertib
-
Los Angeles, California
- +13 more
Oct 7, 2022
DLBCL Trial in United Kingdom (AZD 2014, Rituximab)
Completed
- Diffuse Large B-Cell Lymphoma
- AZD 2014
- Rituximab
-
Aberdeen, United Kingdom
- +8 more
Nov 4, 2020
NSCLC Metastatic Trial in France (AZD2014, AZD4547, AZD5363)
Active, not recruiting
- Non-small Cell Lung Cancer Metastatic
- AZD2014
- +10 more
-
Avignon, France
- +36 more
Jul 29, 2022
Metastatic Breast Cancer Trial in France (AZD2014, AZD4547, AZD5363)
Active, not recruiting
- Metastatic Breast Cancer
- AZD2014
- +18 more
-
Angers, France
- +24 more
Mar 8, 2022
Advanced Cancer Trial in United Kingdom (AZD2014 3 on/4 off & weekly paclitaxel, AZD2014 2 on/5 off & weekly paclitaxel)
Completed
- Advanced Cancer
- AZD2014 3 on/4 off & weekly paclitaxel
- AZD2014 2 on/5 off & weekly paclitaxel
-
Cambridge, Cambridgeshire, United Kingdom
- +3 more
Feb 27, 2020
Glioblastoma Multiforme Trial in Canada (AZD2014)
Completed
- Glioblastoma Multiforme
- AZD2014
-
Calgary, Alberta, Canada
- +3 more
Apr 7, 2020
NSCLC, Carcinoma, Squamous Cell, Adenocarcinoma Trial in United Kingdom (AZD4547, Vistusertib, Palbociclib)
Active, not recruiting
- Non-Small Cell Lung Cancer
- +2 more
- AZD4547
- +10 more
-
Aberdeen, United Kingdom
- +24 more
Nov 2, 2021
Advanced Castrate-resistant Prostate Cancer CRPC, Squamous NSCLC sqNSCLC, Triple Negative Breast Cancer TNBC Trial in Worldwide
Completed
- Advanced Castrate-resistant Prostate Cancer CRPC
- +2 more
- Part A: AZD8186 monotherapy
- +5 more
-
Boston, Massachusetts
- +12 more
May 28, 2020
DLBCL, Richter Syndrome Trial in United Kingdom, United States (acalabrutinib, vistusertib)
Terminated
- DLBCL
- Richter Syndrome
-
Fairway, Kansas
- +10 more
Jan 4, 2021
Prostate Cancer Trial in Cambridge (AZD2014)
Completed
- Prostate Cancer
- AZD2014
-
Cambridge, Cambridgeshire, United KingdomCambridge University Hospitals NHS Foundation Trust
Jul 15, 2019
Solid Tumor Trial in Seoul (Vistusertib(AZD2014))
Withdrawn
- Solid Tumor
-
Seoul, Korea, Republic ofSamsung Medical Center
May 17, 2019
Solid Tumor Trial in Seoul (Vistusertib(AZD2014))
Withdrawn
- Solid Tumor
-
Seoul, Korea, Republic ofSamsung Medical Center
May 17, 2019
Stomach Tumors Trial in Seoul (AZD2014)
Terminated
- Stomach Neoplasms
- AZD2014
-
Seoul, Korea, Republic ofSamsung Medical Center
May 17, 2019
Solid Malignancies Trial in Manchester ([14C]AZD2014, Multiple dose AZD2014, Fulvestrant)
Completed
- Solid Malignancies
- [14C]AZD2014
- +3 more
-
Manchester, United KingdomResearch Site
Jan 25, 2019
Cancer of Stomach Trial in Seoul (AZD2014)
Terminated
- Cancer of Stomach
- AZD2014
-
Seoul, Korea, Republic ofSamsung Medical Center
May 17, 2019
Advanced Gastric Adenocarcinoma Trial in Seoul (AZD5363, paclitaxel, AZD2014)
Terminated
- Advanced Gastric Adenocarcinoma
- AZD5363
- +2 more
-
Seoul, Korea, Republic ofSamsung Medical center
May 17, 2019
Estrogen Receptor Positive Breast Cancer Trial in Worldwide (AZD2014, Everolimus, Fulvestrant)
Unknown status
- Estrogen Receptor Positive Breast Cancer
- AZD2014
- +2 more
-
Angers, France
- +78 more
Feb 24, 2020
Small Cell Lung Cancer Trial in Seoul (vistusertib (AZD2014))
Terminated
- Small Cell Lung Cancer
- vistusertib (AZD2014)
-
Seoul, Korea, Republic ofSamsung Medical center
Sep 18, 2018
Muscle Invasive Bladder Cancer Trial in Worldwide (AZD4547, MEDI4736, Olaparib)
Active, not recruiting
- Muscle Invasive Bladder Cancer
- AZD4547
- +6 more
-
Los Angeles, California
- +26 more
Oct 17, 2022
Squamous Non Small Cell Lung Cancer Trial in Germany, Spain, United States (Open-label AZD2014, paclitaxel)
Terminated
- Squamous Non Small Cell Lung Cancer
- Open-label AZD2014
- paclitaxel
-
Boston, Massachusetts
- +6 more
Jun 4, 2018
Advanced Gastric Adenocarcinoma Trial in Seoul (AZD1775, paclitaxel)
Completed
- Advanced Gastric Adenocarcinoma
-
Seoul, Korea, Republic ofSamsung Medical center
Jun 13, 2022
Peripheral T Cell Lymphoma Trial in Zhengzhou (Golidocitinib, CHOP Regimen)
Not yet recruiting
- Peripheral T Cell Lymphoma
- Golidocitinib
- CHOP Regimen
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Jul 18, 2023
Ovarian Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma Trial in Canada, Singapore, United States
Active, not recruiting
- Ovarian Brenner Tumor
- +11 more
- Adavosertib
- +5 more
-
Duarte, California
- +15 more
Aug 11, 2022